These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 3134851)
1. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp. Schmitt HJ; Bernard EM; Andrade J; Edwards F; Schmitt B; Armstrong D Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851 [TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Ryder NS; Leitner I Med Mycol; 2001 Feb; 39(1):91-5. PubMed ID: 11270414 [TBL] [Abstract][Full Text] [Related]
3. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro]. Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206 [TBL] [Abstract][Full Text] [Related]
4. [In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole]. Goudard M; Regli P; Buffard Y; Gabriel B Pathol Biol (Paris); 1988 Feb; 36(2):139-43. PubMed ID: 3279381 [TBL] [Abstract][Full Text] [Related]
5. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp. Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398 [TBL] [Abstract][Full Text] [Related]
6. Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species. Colombo AL; McGough DA; Rinaldi MG Mycopathologia; 1994 Dec; 128(3):129-33. PubMed ID: 7739726 [TBL] [Abstract][Full Text] [Related]
7. In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species. Kantarcioğlu AS; Yucel A J Chemother; 2002 Dec; 14(6):562-7. PubMed ID: 12583546 [TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp. Moore CB; Law D; Denning DW J Antimicrob Chemother; 1993 Dec; 32(6):831-6. PubMed ID: 8144422 [TBL] [Abstract][Full Text] [Related]
9. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B. Moore CB; Walls CM; Denning DW Antimicrob Agents Chemother; 2001 Jun; 45(6):1882-5. PubMed ID: 11353643 [TBL] [Abstract][Full Text] [Related]
10. In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp. Hughes CE; Harris C; Moody JA; Peterson LR; Gerding DN Antimicrob Agents Chemother; 1984 May; 25(5):560-2. PubMed ID: 6329088 [TBL] [Abstract][Full Text] [Related]
11. Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method. Lass-Flörl C; Speth C; Kofler G; Dierch MP; Gunsilius E; Würzner R Int J Antimicrob Agents; 2003 Mar; 21(3):229-33. PubMed ID: 12636983 [TBL] [Abstract][Full Text] [Related]
12. Anti-Aspergillus activities of plant essential oils and their combination effects with ketoconazole or amphotericin B. Shin S Arch Pharm Res; 2003 May; 26(5):389-93. PubMed ID: 12785735 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus species. Denning DW; Hanson LH; Stevens DA Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):693-7. PubMed ID: 2171940 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods. Pfaller MA; Messer SA; Motyl MR; Jones RN; Castanheira M Antimicrob Agents Chemother; 2013 Feb; 57(2):1065-8. PubMed ID: 23229479 [TBL] [Abstract][Full Text] [Related]
15. Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999. Chandrasekar PH; Cutright JL; Manavathu EK Diagn Microbiol Infect Dis; 2001 Dec; 41(4):211-4. PubMed ID: 11777662 [TBL] [Abstract][Full Text] [Related]
16. In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto. Fernández MS; Rojas FD; Cattana ME; Sosa Mde L; Iovannitti CA; Lass-Flörl C; Giusiano GE Antimicrob Agents Chemother; 2015; 59(6):3619-22. PubMed ID: 25824228 [TBL] [Abstract][Full Text] [Related]
17. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology. Meletiadis J; Antachopoulos C; Stergiopoulou T; Pournaras S; Roilides E; Walsh TJ Antimicrob Agents Chemother; 2007 Sep; 51(9):3329-37. PubMed ID: 17576838 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. Araujo R; Pina-Vaz C; Rodrigues AG Int J Antimicrob Agents; 2007 Jan; 29(1):108-11. PubMed ID: 17189101 [TBL] [Abstract][Full Text] [Related]
19. Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus. Martinez J; Torres JM; Arteaga F; Foz-Tena A Mycopathologia; 1978 Nov; 64(3):147-51. PubMed ID: 104180 [TBL] [Abstract][Full Text] [Related]
20. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis. Schmitt HJ; Edwards F; Andrade J; Niki Y; Armstrong D Chemotherapy; 1992; 38(2):118-26. PubMed ID: 1317280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]